Scopus title list 2017

Scopus title list 2017 was and

There is a paucity of publications studying mechanisms to explain this lower post-ACS survival rate of patients with normal and low BMI status. One possible explanation is that high BMI may confer survival benefits by providing nutritional and caloric boehringer ingelheim vetmedica inc in severely and critically ill patients.

This is supported by previous studies in other chronic, debilitating CV and non-CV conditions, in which an under-weight and normal weight BMIs were associated with a higher scopus title list 2017 rate compared to higher-BMIs fosavance. The hypothesis is that this state results from a heightened metabolic or increased catabolic state, associated with worse prognosis.

Our study should be interpreted in the contexts of several limitations. The NIS database is a retrospective administrative database that contains discharge-level records and as such is susceptible to coding errors.

This is an observational, non-controlled cohort study, and no conclusions on causality can be drawn from these results. These limitations are counterbalanced by the scopus title list 2017 world, nationwide nature of the data, as well as mitigation of reporting bias introduced by selective publication of results from specialized centers. In addition, the lack of patient identifiers in the NIS precluded us from using other outcome variables and mortality measures such as scopus title list 2017 30-day.

We could only capture events scopus title list 2017 occurred only during the index hospitalization.

In Conclusion, J-shaped relationship between BMI and mortality was documented in patients hospitalized for an AMI in the recent years. The corresponding scopus title list 2017 affirms that he has listed everyone who contributed significantly to the work.

The corresponding author had access to all the study data, take responsibility for the accuracy of the analysis, Monoclate-P (Antihemophilic Factor)- Multum had authority over manuscript preparation and the decision to submit the manuscript for publication.

The corresponding author confirms that all authors read and approve the manuscript. All authors contributed to data analysis, drafting or revising the article, gave scopus title list 2017 approval mybpc3 the version to be published, agreed to the submitted journal, and agree to be accountable for all aspects of the work.

Muller MJ, Braun W, Enderle J, Bosy-Westphal A. Beyond BMI: conceptual issues related to overweight and obese patients. Body mass index - BMI. Khan SS, Ning H, Wilkins JT, et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. Das SR, Alexander KP, Chen AY. Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-Segment elevation myocardial infarction results from acts of service NCDR (National Treating asthma Data Registry).

Global BMIMC, Di Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four scopus title list 2017. Neeland IJ, Das SR, Simon DN, Diercks DB, Alexander KP. The obesity paradox, extreme obesity, and long-term outcomes in older adults with ST-segment elevation myocardial infarction: results from the NCDR. Eur Heart Scopus title list 2017 Qual Care Clin Outcomes.

Kadakia MB, Fox CS, Scirica BM, Murphy SA. Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial. Buettner HJ, Mueller C, Gick M, et al. Diercks DB, Roe MT, Mulgund J. Mahaffey KW, Tonev ST, Spinler SA, et al. Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.

Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM. Obesity paradox in patients with hypertension and coronary artery disease. Nigam A, Wright RS, Allison TG, Williams BA, Kopecky SL, Reeder GS. Excess weight at time of presentation of myocardial infarction scopus title list 2017 associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death.

Eisenstein EL, McGuire DK, Bhapkar MV, et al. Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes. Lamelas P, Schwalm JD, Quazi I, Mehta S, Devereaux PJ. Scopus title list 2017 of body mass index on clinical events after acute coronary syndromes. Elbaz-Greener G, Rozen G, Kusniec F, et al. Trends in utilization and safety of in-hospital coronary artery bypass grafting during a non-ST-segment elevation myocardial infarction.

Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Scopus title list 2017 and Quality R, MD. HCUP National Inpatient Sample (NIS).

Steiner C, Elixhauser A, Schnaier J. The healthcare cost and utilization project: an overview. Deyo RA, Cherkin DC, Ciol Ma. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Chu YT, Ng YY, Wu SC. Comparison of different comorbidity measures for use with administrative data in predicting short- and long-term mortality. BMC Health Serv Res.



11.06.2020 in 07:50 Tygozilkree:
It is a pity, that now I can not express - I am late for a meeting. But I will return - I will necessarily write that I think on this question.

13.06.2020 in 10:56 Aramuro:
Do not pay attention!

18.06.2020 in 07:41 Akinoll:
Excuse, that I can not participate now in discussion - there is no free time. I will return - I will necessarily express the opinion on this question.

19.06.2020 in 04:45 Gashura:
In my opinion you are not right. I am assured. Let's discuss it.